Alafia AI, Inc. (“ALAFIA”), a leader in omics computing and precision medicine, is today unveiling an expansion of its high-performance computing (HPC) product line to address the growing demand for scalable, heterogeneous computing in the biopharmaceutical and application development industries. ALAFIA’s new personal supercomputers—AIVAS, VIKI, and GLADIS—are designed to provide low-latency, scalable solutions with higher compute density and improved power efficiency. These systems are optimized for mission-critical, data-intensive workloads, including AI training, inference, and large language model (LLM) applications.
These systems offer cutting-edge capabilities with faster unified memory, expanded addressable memory of up to 8 terabytes (TB), and over 1,092 GB/s of memory bandwidth at speeds exceeding 9.6 Gbps (9,600 MT/s). This impressive configuration enables developers to seamlessly interact with LLMs containing over 405 billion parameters, processing more than 200 tokens per second. The result is a new level of performance and efficiency that outpaces any AI PC currently available.
ALAFIA’s personal supercomputers are specifically engineered to support demanding use cases—from real-time AI inference to molecular dynamics and protein design—enabling compute- and memory-intensive applications to run smoothly, securely, and encrypted on-device.
“We understand the unique needs of doctors, biotechnologists, and pharmaceutical developers, which is why we’ve created a family of products tailored to their specific requirements,” said Dr. Tillman Pearce, Chief Medical Officer of ALAFIA.
Showcasing at Supercomputing Conference (SC24)
At the Supercomputing Conference (SC24), taking place November 17-21, ALAFIA will showcase GLADIS, its next-generation all-in-one interactive supercomputer. Designed for HPC developers and biopharmaceutical companies, GLADIS features 256 Ampere® Arm CPU cores, dual NVLinked NVIDIA H100 Tensor Core GPUs, and an RTX 6000 Ada Generation Graphics Card, totaling 47,359 NVIDIA CUDA-accelerated GPU cores. With 236 GB of unified high-bandwidth memory and a remarkable 4,096 GB (4 TB) of system memory, GLADIS is poised to redefine the performance capabilities of interactive supercomputing. The system will be on display at theCube’s booth #3513.
Intelligent Architecture for Accelerated Innovation
ALAFIA’s systems integrate a high-performance architecture that optimizes both low-latency, single-threaded performance and high-throughput, massively parallel compute performance. Designed to accelerate medical, scientific, and HPC applications, ALAFIA’s open architecture enhances mathematical algorithms by reducing noise and increasing numerical accuracy. The company’s seamless integration of software and hardware minimizes overhead and maximizes performance for mission-critical workloads.
ALAFIA’s interactive supercomputers deliver the industry’s highest performance and scalability, combining advanced memory bandwidths, storage capacity, and parallel computing power. The systems utilize 256 to 1,024 next-generation machine learning (ML) SIMD Ampere® Arm CPU vectorization engines and AI accelerators, enabling developers to address the most complex challenges in real-time data visualization, processing, and decision-making.
“We’ve supported ALAFIA from the beginning in their mission to bring cutting-edge medical research tools to clinicians, enabling decisions that once took hours or days to be made in seconds,” said Joe Speed, Head of Edge at Ampere Computing.
AIVAS Honored with CES Innovation Award
ALAFIA’s flagship supercomputer, AIVAS, has been named a double CES 2025 Innovation Awards Honoree in both the Computer Hardware and Artificial Intelligence categories by the Consumer Technology Association (CTA). AIVAS will be on display at CES 2025 in Las Vegas, January 7-10.
About ALAFIA AI, Inc.
ALAFIA AI, Inc. is revolutionizing precision medicine with its high-performance computing platform, designed to accelerate scientific and medical discoveries in hospitals, cancer centers, research institutions, and biopharmaceutical companies. ALAFIA’s mission is to create an intelligent healthcare ecosystem that ensures personalized, adaptable care for every patient. By combining advanced computing with the latest in medical research, ALAFIA is transforming the future of healthcare.
